DTC spend down 3% in '07, but mass-market ads still strong

Share this article:
Drug industry spending on consumer advertising dropped 3% in 2007 to $5.15 billion, from $5.31 billion in 2006, but spending on product advertising, particularly TV and print, continued to climb. 

Pharmas cut back sharply on corporate advertising – from $577 million in 2006 to $247 million in 2007, according to TNS Media Intelligence. But product advertising was up 3% to $4.9 billion, from $4.73 billion in 2006. 

For product advertising, newspapers took a hit as spending was halved, to $75 million from $152 million. Radio spending fell 45%, from $55 million to $30 million. Perhaps most remarkably, Internet spending slid 5%, from $163 million to $155 million, though that figure only reflects display advertising – not spending on search engine optimization or websites. 

Spending on TV product ads rose 7% to $2.87 billion from $2.66 billion in 2006, while spending on product ads in magazines climbed 4% to $1.76 billion from $1.68 billion in 2006.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...